Retraction
Combination therapy with Nab-paclitaxel and the interleukin-15 fused with anti-human serum albumin nanobody as a synergistic treatment for colorectal cancer
Paper Information
Record ID:
40436
Author(s):
Journal:
Publication Date:
January 12, 2022
Retraction Date:
November 09, 2022
(3.0 years years ago)
Subjects:
Institutions:
- Department of Laboratory Medicine, Dongtai People’s Hospital & Dongtai Hospital of Nantong University, Yancheng, China
- Department of Laboratory Medicine, Shanghai Tongji Hospital, Shanghai, China
- Department of Pathology, Tinghu People’s Hospital, Yancheng, China
- Department of Laboratory Medicine, Tinghu People’s Hospital of Yancheng City, Yancheng, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Taylor and Francis
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1080/21655979.2022.2143469Citations (4)
4
Total Citations3
Post-Retraction(75.0%)
0
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
3
Within 1 year
0
After 2+ years
237
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy
Songlin Liu, Haiyang Wang, Xinzhe Shao et al. (9 authors)
Journal of Nanobiotechnology
Open Access
Published: Jul 2023
15 citations
15 citations
237 days after retraction
Nanobodies: Robust miniprotein binders in biomedicine
Jeffrey Yong Joon Kim, Zhe Sang, Yufei Xiang et al. (5 authors)
Advanced Drug Delivery Reviews
Open Access
Published: Feb 2023
49 citations
49 citations
90 days after retraction
Isoquercitrin Induces Endoplasmic Reticulum Stress and Immunogenic Cell Death in Gastric Cancer Cells
Jiang Liu, Lijun Ren, HaoWen Wang et al. (4 authors)
Biochemical Genetics
Published: Dec 2022
31 citations
31 citations
29 days after retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
3.0 years
Open Access:
Yes
Last Checked:
Jul 24, 2025